BLUE - bluebird bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 56.63B
Enterprise Value 35.57B
Trailing P/E N/A
Forward P/E 1-9.19
PEG Ratio (5 yr expected) 10.05
Price/Sales (ttm)117.33
Price/Book (mrq)4.05
Enterprise Value/Revenue 398.58
Enterprise Value/EBITDA 6-8.38

Trading Information

Stock Price History

Beta (3Y Monthly) 2.62
52-Week Change 3-26.28%
S&P500 52-Week Change 3-0.33%
52 Week High 3176.55
52 Week Low 387.49
50-Day Moving Average 3129.81
200-Day Moving Average 3135.84

Share Statistics

Avg Vol (3 month) 3562.01k
Avg Vol (10 day) 3481.24k
Shares Outstanding 5N/A
Float 55.01M
% Held by Insiders 10.65%
% Held by Institutions 1112.01%
Shares Short (Jul 31, 2019) 47.5M
Short Ratio (Jul 31, 2019) 414.32
Short % of Float (Jul 31, 2019) 427.87%
Short % of Shares Outstanding (Jul 31, 2019) 413.58%
Shares Short (prior month Jun 28, 2019) 48.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,199.10%

Management Effectiveness

Return on Assets (ttm)-22.39%
Return on Equity (ttm)-42.32%

Income Statement

Revenue (ttm)56.54M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)69.40%
Gross Profit (ttm)-394.89M
EBITDA -664.96M
Net Income Avi to Common (ttm)-654.73M
Diluted EPS (ttm)-12.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.25B
Total Cash Per Share (mrq)22.69
Total Debt (mrq)194.22M
Total Debt/Equity (mrq)11.87
Current Ratio (mrq)8.02
Book Value Per Share (mrq)29.63

Cash Flow Statement

Operating Cash Flow (ttm)-496.23M
Levered Free Cash Flow (ttm)-332.28M